Recognizes Rare Disease Day 2023
Supports raising awareness and the need to expand access to treatment options for patients living with rare conditions ISTANBUL, TÜRKIYE,...
top of page
Search
Erkim Public Relations
- Jul 19, 2022
- 4 min
Nabriva Therapeutics Expands XENLETA® Presence with Exclusive Agreement with Er-Kim Pharmaceuticals
DUBLIN, Ireland and FORT WASHINGTON, Pa., July 18, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical...
Erkim Public Relations
- Jun 9, 2022
- 1 min
Er-Kim Partners with Kyowa Kirin to Commercialize Palliative Care Portfolio in Eleven CEE Countries
Sofia, Bulgaria – May, 2022 – Er-Kim, a regional specialty pharmaceutical company, announced today the signature of an exclusive...
Erkim Public Relations
- Mar 1, 2022
- 3 min
Quoin Pharmaceuticals Extends Exclusive Distribution Agreement with Er-Kim for its Lead Asset, QRX00
ASHBURN, Va., March 01, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty...
Erkim Public Relations
- Feb 10, 2022
- 3 min
Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Er-Kim for its Lead Asset, QRX003
ASHBURN, Va., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty...
bottom of page